ACADIA Pharmaceuticals Stock Target Price and Analyst Consensus
| ACAD Stock | USD 17.07 0.12 0.70% |
The current analyst and expert consensus on ACADIA Pharmaceuticals is Strong Buy with 6 buy recommendations. The current projected ACADIA Pharmaceuticals target price consensus is 31.25, with 20 analyst opinions. The most common way ACADIA Pharmaceuticals analysts use to provide public buy-or-sell recommendation is financial statements analysis. They also talk to ACADIA Pharmaceuticals executives, vendors, and/or customers. ACADIA Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected ACADIA Pharmaceuticals target price to derive its highest and lowest estimates based on target price estimated volatility of 0.0. Check out Macroaxis Advice on ACADIA Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade ACADIA Stock refer to our How to Trade ACADIA Stock guide.
Lowest Forecast 28.44 | Highest Forecast 34.69 | Target Price 31.25 |
ACADIA |
It's important to approach ACADIA Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize ACADIA Pharmaceuticals price targets
ACADIA Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using ACADIA Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:- Look at ACADIA Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if ACADIA Pharmaceuticals' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional ACADIA Pharmaceuticals Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of ACADIA Pharmaceuticals is a key component of ACADIA Pharmaceuticals valuation and have some predictive power on the future returns of a ACADIA Pharmaceuticals.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ACADIA Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | FinTech Invested over 70 shares | |
 | Chemicals Invested over 40 shares | |
 | Driverless Cars Invested over 200 shares | |
 | Banking Invested over 30 shares | |
 | Cash Cows Invested few shares | |
 | Automobiles and Trucks Invested over 200 shares | |
 | Business Services Invested few shares | |
 | Momentum Invested over 200 shares | |
 | Manufacturing Invested over 40 shares | |
Check out Macroaxis Advice on ACADIA Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade ACADIA Stock refer to our How to Trade ACADIA Stock guide.Note that the ACADIA Pharmaceuticals information on this page should be used as a complementary analysis to other ACADIA Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for ACADIA Stock analysis
When running ACADIA Pharmaceuticals' price analysis, check to measure ACADIA Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACADIA Pharmaceuticals is operating at the current time. Most of ACADIA Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ACADIA Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ACADIA Pharmaceuticals' price. Additionally, you may evaluate how the addition of ACADIA Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
The data published in ACADIA Pharmaceuticals' official financial statements usually reflect ACADIA Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of ACADIA Pharmaceuticals. For example, before you start analyzing numbers published by ACADIA accountants, it's critical to develop an understanding of what ACADIA Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of ACADIA Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ACADIA Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in ACADIA Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of ACADIA Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of ACADIA Pharmaceuticals' management manipulating its earnings.